Lista de obras - Andrew Harkin - Dominio Público Uruguay

A role for serotonin in the antidepressant activity of NG-Nitro-L-arginine, in the rat forced swimming test.

artículo científico publicado en 2009

A study of VitalView for behavioural and physiological monitoring in laboratory rats.

artículo científico publicado en 2002

A toxicokinetic study of nickel-induced immunosuppression in rats

artículo científico publicado en 2003

Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.

artículo científico publicado en 1999

Acute stress suppresses pro-inflammatory cytokines TNF-alpha and IL-1 beta independent of a catecholamine-driven increase in IL-10 production

artículo científico publicado en 2004

Adenosine A1 receptor blockade mimics caffeine's attenuation of ethanol-induced motor incoordination

artículo científico publicado en 2004

C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy.

artículo científico publicado en 2013

Caffeine induces a profound and persistent tachycardia in response to MDMA ("Ecstasy") administration

artículo científico publicado en 2006

Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").

artículo científico publicado en 2005

Characterisation of the antidepressant properties of nitric oxide synthase inhibitors in the olfactory bulbectomised rat model of depression

artículo científico

Characterization of d-fenfluramine-induced hypothermia: evidence for multiple sites of action

article

Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat.

artículo científico publicado en 2006

Clenbuterol activates the central IL-1 system via the β2-adrenoceptor without provoking inflammatory response related behaviours in rats

artículo científico publicado en 2016

Corrigendum to: “Noradrenergic lesion antagonizes desipramine-induced adaptation of NMDA receptors” [Eur. J. Pharmacol. 389 (2000) 187–192]

artículo científico publicado en 2000

DNA methylation differences at the glucocorticoid receptor gene in depression are related to functional alterations in hypothalamic–pituitary–adrenal axis activity and to early life emotional abuse

article

Diurnal Hypothalamic-Pituitary-Adrenal Axis Measures and Inflammatory Marker Correlates in Major Depressive Disorder.

artículo científico publicado en 2017

Dopamine D1 receptor-mediated intracellular responses in the hypothalamus after co-administration of caffeine with MDMA.

artículo científico publicado en 2011

Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test

artículo científico publicado en 2000

Effects of acute and chronic antidepressant administration on phencyclidine (PCP) induced locomotor hyperactivity

artículo científico publicado en 1999

Effects of brief pulse and ultrabrief pulse electroconvulsive stimulation on rodent brain and behaviour in the corticosterone model of depression

artículo científico publicado en 2014

Expression of glucocorticoid inducible genes is associated with reductions in cornu ammonis and dentate gyrus volumes in patients with major depressive disorder

artículo científico publicado en 2014

Glial fibrillary acidic protein (GFAP) immunoreactivity correlates with cortical perfusion parameters determined by bolus tracking arterial spin labelling (bt-ASL) magnetic resonance (MR) imaging in the Wistar Kyoto rat.

artículo científico publicado en 2016

Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?

artículo científico publicado en 2008

Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour

artículo científico publicado en 2014

Investigation of the mechanisms mediating MDMA "Ecstasy"-induced increases in cerebro-cortical perfusion determined by btASL MRI.

artículo científico publicado en 2014

Ketamine and depression: A special kase for kynurenic acid?

Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism.

artículo científico publicado en 2013

L-alpha-amino adipic acid provokes depression-like behaviour and a stress related increase in dendritic spine density in the pre-limbic cortex and hippocampus in rodents

scientific article published on 09 January 2019

L-alpha-aminoadipic acid restricts dopaminergic neurodegeneration and motor deficits in an inflammatory model of Parkinson's disease in male rats

artículo científico publicado en 2019

Lipids and essential fatty acids in patients presenting with self-harm

artículo científico publicado en 2007

MDMA 'ecstasy' increases cerebral cortical perfusion determined by bolus-tracking arterial spin labelling (btASL) MRI

artículo científico publicado en 2013

Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-alpha independent of a beta-adrenoceptor-mediated increase in interleukin-10.

artículo científico publicado en 2004

Methylenedioxymethamphetamine-induced suppression of interleukin-1beta and tumour necrosis factor-alpha is not mediated by serotonin

artículo científico publicado en 2001

Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine

artículo científico publicado en 2003

Metyrapone displays antidepressant-like properties in preclinical paradigms.

artículo científico publicado en 1999

Modulation of MK-801-induced behaviour by noradrenergic agents in mice

artículo científico publicado en 2001

Muscling in on depression

artículo científico publicado en 2014

Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test

artículo científico publicado en 2004

Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test

artículo científico publicado en 1999

Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex

artículo científico publicado en 2010

Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration.

artículo científico publicado en 2010

Noradrenaline acting on astrocytic β₂-adrenoceptors induces neurite outgrowth in primary cortical neurons

artículo científico publicado en 2013

Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge.

artículo científico publicado en 2010

Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration

artículo científico publicado en 2008

Noradrenergic lesion antagonizes desipramine-induced adaptation of NMDA receptors

scientific article published on 01 February 2000

Olfactory bulbectomy in mice induces alterations in exploratory behavior

artículo científico publicado en 2005

Pharmacological targeting of β2 -adrenoceptors is neuroprotective in the LPS inflammatory rat model of Parkinson's disease

artículo científico publicado en 2019

Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression

artículo científico publicado en 2012

Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats

artículo científico publicado en 2001

Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat.

artículo científico publicado en 1999

Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats

artículo científico publicado en 2008

Regional specific modulation of neuronal activation associated with nitric oxide synthase inhibitors in an animal model of antidepressant activity

artículo científico publicado en 2016

Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors

artículo científico publicado en 2003

Small-molecule inhibitors at the PSD-95/nNOS interface have antidepressant-like properties in mice.

artículo científico publicado en 2013

Small-molecule inhibitors at the PSD-95/nNOS interface protect against glutamate-induced neuronal atrophy in primary cortical neurons

artículo científico publicado en 2015

Soluble beta amyloid evokes alteration in brain norepinephrine levels: role of nitric oxide and interleukin-1.

artículo científico publicado en 2015

Stimulation of central β2-adrenoceptors suppresses NFκB activity in rat brain: a role for IκB.

artículo científico publicado en 2013

Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders.

artículo científico

The PSD-95/nNOS complex: new drugs for depression?

artículo científico publicado en 2011

The functional sensitisation of sigma receptors following chronic selective serotonin reuptake inhibitor treatment

artículo científico publicado en 1998

The β2-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity.

artículo científico publicado en 2010

Treatment with the noradrenaline re-uptake inhibitor atomoxetine alone and in combination with the α2-adrenoceptor antagonist idazoxan attenuates loss of dopamine and associated motor deficits in the LPS inflammatory rat model of Parkinson's disease

artículo científico publicado en 2018

Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation

artículo científico publicado en 2012

Varying responses to the rat forced-swim test under diurnal and nocturnal conditions

scientific article published on 01 June 2000

Lista de obras de Andrew Harkin

A role for serotonin in the antidepressant activity of NG-Nitro-L-arginine, in the rat forced swimming test.

A study of VitalView for behavioural and physiological monitoring in laboratory rats.

A toxicokinetic study of nickel-induced immunosuppression in rats

Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.

Acute stress suppresses pro-inflammatory cytokines TNF-alpha and IL-1 beta independent of a catecholamine-driven increase in IL-10 production

Adenosine A1 receptor blockade mimics caffeine's attenuation of ethanol-induced motor incoordination

C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy.

Caffeine induces a profound and persistent tachycardia in response to MDMA ("Ecstasy") administration

Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").

Characterisation of the antidepressant properties of nitric oxide synthase inhibitors in the olfactory bulbectomised rat model of depression

Characterization of d-fenfluramine-induced hypothermia: evidence for multiple sites of action

Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat.

Clenbuterol activates the central IL-1 system via the β2-adrenoceptor without provoking inflammatory response related behaviours in rats

Corrigendum to: “Noradrenergic lesion antagonizes desipramine-induced adaptation of NMDA receptors” [Eur. J. Pharmacol. 389 (2000) 187–192]

DNA methylation differences at the glucocorticoid receptor gene in depression are related to functional alterations in hypothalamic–pituitary–adrenal axis activity and to early life emotional abuse

Diurnal Hypothalamic-Pituitary-Adrenal Axis Measures and Inflammatory Marker Correlates in Major Depressive Disorder.

Dopamine D1 receptor-mediated intracellular responses in the hypothalamus after co-administration of caffeine with MDMA.

Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test

Effects of acute and chronic antidepressant administration on phencyclidine (PCP) induced locomotor hyperactivity

Effects of brief pulse and ultrabrief pulse electroconvulsive stimulation on rodent brain and behaviour in the corticosterone model of depression

Expression of glucocorticoid inducible genes is associated with reductions in cornu ammonis and dentate gyrus volumes in patients with major depressive disorder

Glial fibrillary acidic protein (GFAP) immunoreactivity correlates with cortical perfusion parameters determined by bolus tracking arterial spin labelling (bt-ASL) magnetic resonance (MR) imaging in the Wistar Kyoto rat.

Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?

Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour

Investigation of the mechanisms mediating MDMA "Ecstasy"-induced increases in cerebro-cortical perfusion determined by btASL MRI.

Ketamine and depression: A special kase for kynurenic acid?

Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism.

L-alpha-amino adipic acid provokes depression-like behaviour and a stress related increase in dendritic spine density in the pre-limbic cortex and hippocampus in rodents

L-alpha-aminoadipic acid restricts dopaminergic neurodegeneration and motor deficits in an inflammatory model of Parkinson's disease in male rats

Lipids and essential fatty acids in patients presenting with self-harm

MDMA 'ecstasy' increases cerebral cortical perfusion determined by bolus-tracking arterial spin labelling (btASL) MRI

Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-alpha independent of a beta-adrenoceptor-mediated increase in interleukin-10.

Methylenedioxymethamphetamine-induced suppression of interleukin-1beta and tumour necrosis factor-alpha is not mediated by serotonin

Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine

Metyrapone displays antidepressant-like properties in preclinical paradigms.

Modulation of MK-801-induced behaviour by noradrenergic agents in mice

Muscling in on depression

Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test

Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test

Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex

Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration.

Noradrenaline acting on astrocytic β₂-adrenoceptors induces neurite outgrowth in primary cortical neurons

Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge.

Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration

Noradrenergic lesion antagonizes desipramine-induced adaptation of NMDA receptors

Olfactory bulbectomy in mice induces alterations in exploratory behavior

Pharmacological targeting of β2 -adrenoceptors is neuroprotective in the LPS inflammatory rat model of Parkinson's disease

Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression

Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats

Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat.

Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats

Regional specific modulation of neuronal activation associated with nitric oxide synthase inhibitors in an animal model of antidepressant activity

Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors

Small-molecule inhibitors at the PSD-95/nNOS interface have antidepressant-like properties in mice.

Small-molecule inhibitors at the PSD-95/nNOS interface protect against glutamate-induced neuronal atrophy in primary cortical neurons

Soluble beta amyloid evokes alteration in brain norepinephrine levels: role of nitric oxide and interleukin-1.

Stimulation of central β2-adrenoceptors suppresses NFκB activity in rat brain: a role for IκB.

Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders.

The PSD-95/nNOS complex: new drugs for depression?

The functional sensitisation of sigma receptors following chronic selective serotonin reuptake inhibitor treatment

The β2-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity.

Treatment with the noradrenaline re-uptake inhibitor atomoxetine alone and in combination with the α2-adrenoceptor antagonist idazoxan attenuates loss of dopamine and associated motor deficits in the LPS inflammatory rat model of Parkinson's disease

Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation

Varying responses to the rat forced-swim test under diurnal and nocturnal conditions